Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Gastroenterology, 2026
Increased Perinatal Levels of Chemokine (C-X-C Motif) Ligand 9, Granzyme B, and Matrix Metalloproteinase-10 Are Associated With Pediatric-Onset Inflammatory Bowel Disease: A Nested Case-Control Study Within a Population-Based Birth Cohort

Grännö O., Bergemalm D., Salomon B. et al.

Olink Target 96Immunological & Inflammatory DiseasesPediatricsPatient StratificationPlasmaSerumCord Blood

Aging Cell, 2026
Associations Between Accelerometer‐Assessed Sleep Patterns, Proteomic Signatures, and Hallmarks of Aging in Adulthood

Liu R., Luo J., Zhang Y. et al.

Olink Explore 3072/384NeurologyAgingPathophysiologyPlasma

Neurology Neuroimmunology & Neuroinflammation, 2026
Distinct Multiomic Signatures of Environmental Exposure Drive Immune Dysregulation and Disease Activity in Early Multiple Sclerosis

Falk S., Schulte-Mecklenbeck A., Ostkamp P. et al.

Olink Explore 3072/384NeurologyEnvironmental Health & ToxicologyPathophysiologyPlasma

Cardio-Oncology, 2026
Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients

Yu L., Cao Z., Wang D. et al.

Olink Explore 3072/384OncologyPatient StratificationCross-platform ValidationPlasma

Frontiers in Endocrinology, 2026
Olink proteomics identifies serum protein biomarkers and an age-stratified diagnostic model for diabetes in Chinese patients

Yang Y., Liu S., Xie C. et al.

Olink Target 96Metabolic DiseasesAgingPatient StratificationPlasma

Human Genetics and Genomics Advances, 2026
Multi-omic characterization of the Hispanic/Latino blood lipidome reveals an additional locus and attenuated genetic prediction

Zhu W., Chen H., Highland H. et al.

Olink Explore HTWider Proteomics StudiesEpidemiologyPlasma

Blood Neoplasia, 2026
Deuterium labelling uncovers deregulated myeloid cell kinetics in chronic myelomonocytic leukemia

Hermange G., Zhang Y., Tribut A. et al.

Olink Target 48OncologyHematologyPathophysiologyPlasma

Clinical Journal of the American Society of Nephrology, 2026
Plasma Levels of Growth Differentiation Factor 15 and Adverse Kidney Outcomes

Koh H., Kim H., Heo S. et al.

Olink Explore 3072/384NephrologyPathophysiologyPatient StratificationPlasma

Journal of Translational Autoimmunity, 2026
Late TNFα blockade is associated with systemic immune rewiring without disease control in established experimental autoimmune hepatitis

Buitrago-Molina L., Shi Z., Zhao Z. et al.

Olink Target 96 MouseImmunological & Inflammatory DiseasesHepatologyPathophysiologyMouse Serum

Cell Metabolism, 2026
Immunometabolic endotypes define distinct clinical trajectories in type 2 diabetes

Vuong B., Delépine C., Ratter-Rieck J. et al.

Olink Target 96Metabolic DiseasesPatient StratificationSerum

Brain, Behavior, and Immunity, 2026
Cardiovascular-Kidney-Metabolic Syndrome in neurological and psychiatric disorders: a large multi-national cohort study

Huang Y., Li K., Yang Y. et al.

Olink Explore 3072/384Metabolic DiseasesCVDNeurologyNephrologyPathophysiologyPlasma

Diabetes, Obesity and Metabolism, 2026
Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study

Liao S., Sung G., Liang Y. et al.

Olink Explore 3072/384Metabolic DiseasesCVDPathophysiologyPlasma

Chinese Medical Journal, 2026
Association of serum uric acid with circulating inflammatory proteins and treatment response to ixekizumab in patients with psoriasis: A multicenter prospective cohort study in China

Jiang Y., Guo Z., Yao L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2026
Protein Profiling Identifies Biomarkers for Predicting Disease Severity in Anti-NMDAR Encephalitis

Zhao S., Xu F., Cui L. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPatient StratificationSerumCSF

European Heart Journal, 2026
Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling

Morze J., Björnson E., Mi M. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

BMC Bioinformatics, 2026
Multi-task deep learning for risk stratification and shared molecular architecture of cardiometabolic multimorbidity under fragmented multi-omics

Cao L., Wang J., You S. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Leukemia, 2026
TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy

Rappa G., Ziemann F., White K. et al.

Olink Target 96OncologyHematologyImmunotherapyPatient StratificationSerum

Canadian Journal of Physiology and Pharmacology, 2026
Comparison of endothelin-1 levels in plasma from human coronary arteries measured by enzyme linked immunosorbent assay and Olink high-throughput proteomics platform

Anwar M., Kuc R., Bullock C. et al.

Olink Explore 3072/384CVDTechnology EvaluationPlasma

Medicine, 2026
Gut microbiota, inflammatory proteins, and allergic diseases

Zhu H., Dou M., Jin X.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Medicine, 2026
Causal link between polymyositis and idiopathic pulmonary fibrosis in individuals of European ancestry

Chen M., Tong X., Zhang R. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

4455 publications